Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Abbott Laboratories (NY:ABT)

110.37 -0.88 (-0.79%)
Official Closing Price Updated: 7:00 PM EDT, Aug 17, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 11,462,163
Open 110.04
Bid (Size) 108.66 (100)
Ask (Size) 110.50 (100)
Prev. Close 111.25
Today's Range 109.35 - 111.41
52wk Range 81.97 - 137.49
Shares Outstanding 1,750,942,289
Dividend Yield 2.28%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
If You Invest $100 a Month in SCHD, Here's the Passive Income It Could Deliver in 20 Years ↗
This top dividend ETF is still a reliable long-term income investment. 
Via The Motley Fool
Topics ETFs Retirement Stocks
News headline image
Recent Report Shows That Rep. Richard Dean Dr McCormick Sold Up to $375K Worth of Abbott Laboratories Stock ↗
Records from August 14, 2026 indicate that Representative Richard Dean Dr McCormick of Georgia made a sale of Abbott Laboratories (NYSE:ABT), valued between $25,025 and $375,000, with the transaction... 
Via Benzinga

Performance

YTD
-11.1%
-11.1%
1 Month
+9.6%
+9.6%
3 Month
+25.5%
+25.5%
6 Month
-1.7%
-1.7%
1 Year
-15.3%
-15.3%

More News

Read More
News headline image
The L.A. Lakers Delivered a 1-Year Return of 25%. These ETFs Have Done Even Better. ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Economy
Abbott Laboratories (NYSE:ABT): A Strong Candidate for Quality Investors ↗
Via Chartmill
Unusual volume S&P500 stocks in Thursday's session ↗
Via Chartmill
News headline image
Recession-Proofing Your Portfolio Before the Storm Hits ↗
Via The Motley Fool
Topics Economy
News headline image
The U.S. Labor Market Is Weakening. These 2 Dividend Stocks Look Built to Weather a Recession ↗
Via The Motley Fool
Topics Economy
News headline image
AbbVie Piles on $8 Billion in Debt for Its Apogee Deal -- Should Dividend Investors Worry? ↗
Via The Motley Fool
News headline image
AbbVie vs. Abbott Laboratories: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Solventum Nears Inflection Point As It Begins to Unlock Value ↗
Via MarketBeat
Topics Initial Public Offering
News headline image
This Stock Keeps Raising Its Dividend No Matter What the Market Does -- and Wall Street Thinks It's a Buy Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Abbott Laboratories vs. Eli Lilly: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
Abbott Laboratories vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026? ↗
Via The Motley Fool
News headline image
3 Dividend Stocks to Buy for a Lifetime of Passive Income ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
AbbVie Has Raised Its Dividend for 53 Straight Years and Still Looks Attractively Valued. Is This Dividend King the Smartest Buy in Healthcare Right Now? ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
Why Wall Street Can't Get Enough of This Dividend King ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
3 Reasons to Buy AbbVie Stock Like There's No Tomorrow ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
How Will AbbVie's $10.9 Billion Acquisition of Apogee Impact Its Dividend? ↗
Via The Motley Fool
News headline image
My 2 Favorite Dividend Kings to Buy Right Now ↗
Via The Motley Fool
Topics Intellectual Property
News headline image
This Dividend ETF Yields 3.2% and Is Beating the Nasdaq-100 This Year ↗
Via The Motley Fool
Topics Artificial Intelligence ETFs Stocks
News headline image
These Analysts Increase Their Forecasts On Abbott Following Better-Than-Expected Q2 Results ↗
Via Benzinga
News headline image
Why Abbott Stock Jumped Today ↗
Via The Motley Fool
Explore the top gainers and losers within the S&P500 index in today's session. ↗
Via Chartmill
News headline image
Why Abbott Laboratories Stock Is Suddenly Winning Back Wall Street ↗
Via MarketBeat
News headline image
Dow Jones Hangs On While Memory Chips Take Another Beating ↗
Via The Motley Fool
Topics Stocks

Frequently Asked Questions

Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 110.37
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 08/17/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 193.25B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 193B shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

© Copyright 2015, Penticton Herald, Penticton, BC. Powered by BLOX Content Management System from TownNews.com.